Grace Vanesko
Gastroenterology · Plano, TXNPI 1871579169
Payments from drug & device makers
Across 252 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$416
- Takeda Pharmaceuticals U.S.A., Inc.$325
- Micro-tech Endoscopy USA, Inc.$263
- Bristol Myers Squibb$229
- Pfizer$207
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,06698%
- Education$902%
- Other$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 110 | $2,135 |
| Johnson & Johnson | 18 | $416 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $325 |
| Micro-tech Endoscopy USA, Inc. | 1 | $263 |
| Bristol Myers Squibb | 12 | $229 |
| Pfizer | 13 | $207 |
| Merck | 8 | $163 |
| Ferring Pharmaceuticals Inc. | 9 | $162 |
| Amgen | 6 | $144 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $111 |
| Sanofi | 3 | $83 |
| QOL Medical, LLC | 4 | $80 |
| Boehringer Ingelheim | 3 | $76 |
| Nestle Healthcare Nutrition Inc. | 5 | $75 |
| Ironwood Pharmaceuticals, Inc | 4 | $70 |
| Gilead | 3 | $64 |
| UCB, Inc. | 3 | $64 |
| Intercept Pharmaceuticals, Inc. | 3 | $48 |
| Ardelyx, Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Boston Scientific | 1 | $40 |
| Endo Pharmaceuticals Inc. | 2 | $33 |
| Shire North American Group Inc | 2 | $32 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Welch Allyn | 1 | $30 |
| Lilly USA, LLC | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Organon | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
| Covidien LP | 1 | $12 |
| Gastrogpo, LLC | 2 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- All Products$263
- STELARA$111
- REMICADE$111
How this compares
$5,185 in reported general payments places this provider in the 55th percentile of 1,350 gastroenterology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 15 | $155 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Plano
- Eric LawitzSan Antonio$59.5M
- George DuvallTyler$17.5M
- John FordtranDallas$9.9M
- Timothy RitterSouthlake$7.7M
- Parvez MantryDallas$6.4M
- Mazen NoureddinHouston$6.1M
- Nadege GunnWaco$5.7M
- Michael BrownDallas$5.5M
- James MaherHouston$5.3M
- Stephen HarrisonLive Oak$5.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.